Download presentation
Presentation is loading. Please wait.
Published byΠρόκρις Μακρή Modified over 5 years ago
1
Equity in Pharmaceutical Pricing and Reimbursement: Crossing the Income Divide in Asia Pacific
Rutger Daems, PhD, Edith Maes, DBA, Christoph Glaetzer, Dipl, Kfm Value in Health Regional Issues Volume 2, Issue 1, Pages (May 2013) DOI: /j.vhri Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
2
Fig. 1 International pricing policy framework and process. ATP, ability to pay; CEA, cost-effectiveness analysis; WTP, willingness to pay. Value in Health Regional Issues 2013 2, DOI: ( /j.vhri ) Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
3
Fig. 2 Cost-effectiveness and policy decisions. ICER, incremental cost-effectiveness ratio. Value in Health Regional Issues 2013 2, DOI: ( /j.vhri ) Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
4
Fig. 3 Pricing using HDI- and GNI-based indexes. GNI, gross national income; HDI, human development index; PPP, purchasing power parity. Value in Health Regional Issues 2013 2, DOI: ( /j.vhri ) Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
5
Fig. 4 Trend of equitable discounts in period (selection of countries). Value in Health Regional Issues 2013 2, DOI: ( /j.vhri ) Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
6
Fig. 5 ATP method applied to a globally marketed medicine. ATP, ability to pay; GNI, gross national income; PPP, purchasing power parity. Value in Health Regional Issues 2013 2, DOI: ( /j.vhri ) Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
7
Fig. 6 ATP index per country versus equitable pricing standard. ATP, ability to pay. Value in Health Regional Issues 2013 2, DOI: ( /j.vhri ) Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.